IAG Wealth Partners’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2K Hold
2,750
– – ﹤0.01% 321
2026
Q1
$13.2K Hold
2,750
– – ﹤0.01% 351
2025
Q4
$22.5K Hold
2,750
– – ﹤0.01% 279
2025
Q3
$16.2K Hold
2,750
– – ﹤0.01% 326
2025
Q2
$23.1K Hold
2,750
– – ﹤0.01% 272
2025
Q1
$17.4K Hold
2,750
– – ﹤0.01% 282
2024
Q4
$24.3K Hold
2,750
– – ﹤0.01% 262
2024
Q3
$24.4K Hold
2,750
– – ﹤0.01% 260
2024
Q2
$28.3K Hold
2,750
– – 0.01% 233
2024
Q1
$43.2K Hold
2,750
– – 0.01% 177
2023
Q4
$42.9K Buy
2,750
+120
+5% +$2.23K 0.01% 171
2023
Q3
$53.1K Buy
2,630
+434
+20% +$6.39K 0.01% 146
2023
Q2
$31.5K Hold
2,196
– – 0.01% 199
2023
Q1
$32.1K Hold
2,196
– – 0.01% 177
2022
Q4
$24.8K Hold
2,196
– – 0.01% 193
2022
Q3
$40K Hold
2,196
– – 0.01% 139
2022
Q2
$47K Buy
+2,196
New +$53.2K 0.02% 132

Other funds holding HELP

IAG Wealth Partners's HELP Position: Q2 2026 in Review

IAG Wealth Partners held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2026 at 2,750 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #321.

IAG Wealth Partners first reported a position in HELP in Q2 2022 and has held it in 17 quarters since. The position peaked at $53.1K in Q3 2023. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • IAG Wealth Partners held 2,750 shares of Helus Pharma Inc. Common Stock worth $18.2K as of Q2 2026.
  • IAG Wealth Partners left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of IAG Wealth Partners's portfolio in Q2 2026, its #321 holding.
  • IAG Wealth Partners first reported a position in Helus Pharma Inc. Common Stock in Q2 2022 and has held it in 17 quarters since.
  • IAG Wealth Partners's Helus Pharma Inc. Common Stock position peaked at $53.1K in Q3 2023.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on IAG Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.